Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Osteoporosis 4Prostatic Neoplasms 3Breast Neoplasms 3Vitamin D Deficiency 2Polycystic Ovary Syndrome 2Neoplasms 2Cardiovascular Diseases 2Vitamin D3 1Neuroma 1Melanoma, Cutaneous Malignant 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Locally Advanced Breast Cancer and Large Operable Breast Cancer 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Insulin Resistance 1Fractures, Bone 1Colorectal Adenocarcinoma 1

Interventions

Metformin 5lime 1cinnulin PF 1World Health Organization oral rehydration solution 1Resistance Training 1Pioglitazone 1Liraglutide 1Exercise 1Diet Therapy 1DLBS3233 1Contraceptives, Oral 1Clomiphene 1Cholecalciferol 1Caloric Restriction 1Biguanides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Insulin Resistance × Cholecalciferol × Clear all
NCT02328404 2016-08-04

The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)

Hayat Pharmaceutical Co. PLC

Phase 3 Completed
60 enrolled 37 charts

Insulin Resistance, Polycystic Ovary Syndrome, Vitamin D Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡